Introduction , Depression and mental health are the leading cause of disability and ill health across the globe. According to the latest estimations from (World Health Organization) WHO, more than 300 million people are now living having depression with an increase of more than 18% between 2005 and 2015. Depression is a kind of mental condition that causes individuals to experience depressed mood, loss of interest, feelings of low self-worth, disturbed sleep or appetite, low energy, and poor concentration. An individual who is suffering from depression experiences intense emotions of anxiety, hopelessness, negativity and helplessness , The market for depression screening by disease type is segmented into anxiety, mood disorders, depression, bipolar disorders, psychotic disorders, eating disorders and other mental and behavioral & disorders, in which the anxiety market accounted for the largest market share in 2016 due to growing social and environmental variations, and changing lifestyle among the working class across the globe. , The depression screening market is further segmented into diagnosis. These diagnosis are further segmented into psychological test, lab tests, depression screening tests and others. Global depression screening market by diagnosis is expected to reach USD 1,648.98 million by 2023. , Further, the market is segmented on the basis of treatment, which includes medications, brain-stimulation treatments, substance abuse treatment and others. Medications is one of the main treatment for the depression screening market. , Additionally, the market is further segmented on the basis of end user and is bifurcated into hospitals & clinics, medical research centers, academic institutes and others. Out of which hospitals & clinics holds the largest market share among the all the end users. , On the basis of region the market is segmented into America, Europe, Asia-Pacific and Middle East and Africa. Globally Americas holds the largest market share in 2016 due to various factors such as availability advanced diagnostic and treatment, funding for research, increasing number of patients with mental illness and related disorders.
Key Players: –
Alkermes (Republic of Ireland), ALLERGAN (Republic of Ireland), AstraZeneca (UK), Bristol-Myers Squibb Company (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Novartis AG (Switzerland), Otsuka Holdings Co.,Ltd. (Japan), Pfizer Inc. (US), and others.
Get Free Exclusive Sample of this Premium Report at: https://www.esherpamarketreports.com/request-sample/es-193365/
- Depression Screening manufacturers
- Depression Screening Suppliers
- Depression Screening companies
- Key executive (CEO and COO) and strategy growth manager
To provide insights about factors, influencing and affecting the market growth.
To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
To provide historical and forecast revenue of the market segments based on types, application, end user and others.
To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
Purchase this Report with Full Access & Complete TOC at –https://www.esherpamarketreports.com/purchase/es-193365/
Table of Contents:
1.2 Scope of Study
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 Primary Research
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1.1 GROWING Demand for newly developed Depression Screening
3.1.2 Growing trend of Outsourcing
3.1.3 Growing Depression Screening Industry in developing nations
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 Porters Five forces Model
4.2 Bargaining power of suppliers
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 Threat of Substitutes
4.6 Intensity of Rivalry
5 global Depression Screening market, by Type
6 global Depression Screening market, By Application
7 global Depression Screening market, By Manufacturing Methods
7.1 In-House Manufacturing
7.2 Contract Manufacturing
8 Global Depression Screening market, by region
8.1 North America
8.4 Middle East & Africa
9 Competitive landscape
9.1 Major Strategies adopted by market players
9.1.1 STRATEGIC PARTNERSHIP
9.1.2 Merger & Acquisition
10 company profile
Get Special Discount @ https://www.esherpamarketreports.com/request-discount/es-193365/
eSherpa Market Reports is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
Name: Michael James
Phone: USA: +1 408 757 0560
Email: [email protected]
Organization: eSherpa Market Reports
Latest posts by esherpamr (see all)
- Ready Mix Concrete Market Research Report 2020-2024 | Market Size, Share, Technologies, Trends, Growth Patterns, Investments, CAGR - March 9, 2021
- RNAi for Therapeutic Market in 2020: Global Industry Growth Analysis, Size, Share, Future Trends, Segmentation, Demands and Top Players Updates by Forecast to 2024 - March 9, 2021
- Refractories Market in 2020: Global Industry Growth Analysis, Size, Share, Future Trends, Segmentation, Demands and Top Players Updates by Forecast to 2024 - March 9, 2021